首站-论文投稿智能助手
典型文献
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
文献摘要:
Type 2 diabetes mellitus(T2DM)and nonalcoholic fatty liver disease(NAFLD)are the most problematic metabolic diseases in the world.NAFLD encompasses a spectrum of severity,ranging from simple steato-sis to non-alcoholic steatohepatitis(NASH)and fibrosis,increasing the risk of cirrhosis and hepatocellular carcinoma.Importantly,NAFLD is closely linked to obesity and tightly interrelated with insulin resistance and T2DM.T2DM and NAFLD(T2DM-NAFLD)are called as the Xike Rixijing Disease and Tonglaga Indigestion Disease respectively,in Mongolian medicine.Xike Rixijing Disease maybe develop into Tonglaga Indigestion Disease.Forturnately many Mongolian medicines show efficient treatment of T2DM-NAFLD,such as Agriophyllum squarrosum,Haliyasu(dried powder of camel placenta),Digeda-4(herbs of Lomatogonium carinthiacum,rhizomata of Coptis chinensis,ripe fruits of Gardenia jasminoides,herbs of Dianthus superbus),Guangmingyan Siwei Decoction Powder(Halite,ripe fruits of Terminalia che-bula,rhizomata of Zingiber officinale,fruit clusters of Piper longum),Tonglaga-5(ripe fruits of Punica granatum,barks of Cinnamomum cassia,ripe fruits of Amomum kravanh,fruit clusters of Piper longum,flowers of Carthamus tinctorius),Tegexidegeqi(rhizomata of Inula helenium,ripe fruits of Gardenia jasmi-noides,rhizomata of Platycodon grandiflorum,rhizomata of Coptis chinensis,heartwood of Caesalpinia sap-pan),Ligan Shiliu Bawei San(ripe fruits of Punica granatum,barks of Cinnamomum cassia,ripe fruits of Amomum kravanh,fruit clusters of Piper longum,flowers of Carthamus tinctorius,ripe fruits of Amomum tsao-ko,rhizomata of Zingiber officinale),etc.Principles of Mongolian medicine in treating diseases:by balancing"three essences or roots"and"seven elements",strengthening liver and kidney function,trans-porting nutrients to enhance physical strength and disease resistance,and combined with drugs for com-prehensive conditioning treatment.However,their molecular mechanisms remain unclear.In this review,we prospect that Mongolian medicines might be a promising treatment for T2DM-NAFLD by activating P2X7R/NLRP3/NF-κB inflammatory pathway via lipid-sensitive nuclear receptors(i.e.,FXR and LXR).
文献关键词:
作者姓名:
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao
作者机构:
Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
引用格式:
[1]Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-.Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation)[J].中草药(英文版),2022(03):367-375
A类:
steato,Xike,Rixijing,Tonglaga,Indigestion,Forturnately,Haliyasu,Digeda,Lomatogonium,carinthiacum,rhizomata,superbus,Guangmingyan,Siwei,Halite,bula,kravanh,Tegexidegeqi,helenium,jasmi,noides,Platycodon,grandiflorum,heartwood,Ligan,Shiliu,Bawei,essences
B类:
Mongolian,treating,type,diabetes,mellitus,combined,nonalcoholic,fatty,liver,via,FXR,LXR,mediated,P2X7R,NLRP3,pathway,activation,Type,T2DM,NAFLD,are,most,problematic,metabolic,diseases,world,encompasses,spectrum,severity,ranging,from,simple,steatohepatitis,NASH,fibrosis,increasing,risk,cirrhosis,hepatocellular,carcinoma,Importantly,closely,linked,obesity,tightly,interrelated,insulin,resistance,called,Disease,respectively,maybe,develop,into,many,medicines,show,efficient,treatment,such,Agriophyllum,squarrosum,dried,powder,camel,placenta,herbs,Coptis,chinensis,ripe,fruits,Gardenia,jasminoides,Dianthus,Decoction,Powder,Terminalia,che,Zingiber,officinale,clusters,Piper,longum,Punica,granatum,barks,Cinnamomum,cassia,Amomum,flowers,Carthamus,tinctorius,Inula,Caesalpinia,sap,pan,San,tsao,ko,etc,Principles,by,balancing,three,roots,seven,elements,strengthening,kidney,function,trans,porting,nutrients,enhance,physical,drugs,prehensive,conditioning,However,their,molecular,mechanisms,remain,unclear,this,review,prospect,that,might,promising,activating,inflammatory,lipid,sensitive,nuclear,receptors
AB值:
0.427279
相似文献
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
Hao Shen;Han Yu;Qian-yu Li;Ya-ting Wei;Jing Fu;Hui Dong;Dan Cao;Lin-na Guo;Lei Chen;Yuan Yang;Ying Xu;Meng-chao Wu;Hong-yang Wang;Yao Chen-International Cooperation Laboratory on Signal Transduction,National Center for Liver Cancer,Ministry of Education Key Laboratory on signaling Regulation and Targeting Therapy of Liver Cancer,Shanghai Key Laboratory of Hepato-biliary Tumor Biology,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University/NAVAL Medical University,Shanghai 200433,China;Department of Pathology,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China;Third Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。